Complete financial analysis of Nanalysis Scientific Corp. (NSCIF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nanalysis Scientific Corp., a leading company in the Hardware, Equipment & Parts industry within the Technology sector.
You may be interested
- Pavna Industries Limited (PAVNAIND.NS) Income Statement Analysis – Financial Results
- Vineet Laboratories Limited (VINEETLAB.BO) Income Statement Analysis – Financial Results
- Kentucky First Federal Bancorp (KFFB) Income Statement Analysis – Financial Results
- UTI Asset Management Company Limited (UTIAMC.NS) Income Statement Analysis – Financial Results
- PT Akasha Wira International Tbk (ADES.JK) Income Statement Analysis – Financial Results
Nanalysis Scientific Corp. (NSCIF)
About Nanalysis Scientific Corp.
Nanalysis Scientific Corp., develops, manufactures, and sells compact nuclear magnetic resonance (NMR) spectrometers and magnetic resonance imaging equipment for the pharmaceutical, biotech, chemical, security, food, materials, and education industries. It operates through three segments: Nanalysis, RS2D, and Corporate. The company also offers software module packages; manufactures and sells cutting-edge electronics components for precision analytical instruments; and provides monitoring and supporting services for its NMR technologies. It sells its products directly, as well as through a network of distributors worldwide. The company is headquartered in Calgary, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 28.47M | 24.82M | 16.04M | 7.87M | 8.36M | 8.38M | 7.67M | 5.25M |
| Cost of Revenue | 24.50M | 13.68M | 5.80M | 2.71M | 2.30M | 2.98M | 2.77M | 2.15M |
| Gross Profit | 3.97M | 11.14M | 10.24M | 5.17M | 6.06M | 5.40M | 4.89M | 3.10M |
| Gross Profit Ratio | 13.95% | 44.88% | 63.83% | 65.62% | 72.45% | 64.41% | 63.83% | 59.12% |
| Research & Development | 679.00K | 1.47M | 643.00K | 476.00K | 270.00K | 166.00K | 0.00 | 0.00 |
| General & Administrative | 11.04M | 12.67M | 6.14M | 3.51M | 2.77M | 2.26M | 1.32M | 1.33M |
| Selling & Marketing | 1.35M | 2.36M | 2.14M | 3.24M | 2.45M | 2.52M | 1.96M | 1.57M |
| SG&A | 12.39M | 15.02M | 8.28M | 6.75M | 5.22M | 4.77M | 173.33K | 25.25K |
| Other Expenses | -9.10M | 4.56M | 2.51M | 1.68M | 775.00K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 3.97M | 21.05M | 11.43M | 8.91M | 5.99M | 5.11M | 173.33K | 25.25K |
| Cost & Expenses | 40.09M | 34.73M | 17.23M | 11.62M | 8.30M | 8.09M | 173.33K | 25.25K |
| Interest Income | 0.00 | 76.00K | 2.00K | 328.00K | 59.00K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 902.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 4.67M | 4.65M | 2.58M | 1.75M | 845.00K | 372.00K | 164.71K | 110.96K |
| EBITDA | -8.85M | -5.26M | 1.38M | -1.86M | 484.00K | 485.00K | 1.78M | 324.43K |
| EBITDA Ratio | -31.08% | -19.53% | 12.21% | -17.89% | 29.11% | 8.29% | -2.26% | -0.48% |
| Operating Income | -11.62M | -9.50M | -608.00K | -3.18M | 1.59M | 323.00K | -173.33K | -25.25K |
| Operating Income Ratio | -40.82% | -38.26% | -3.79% | -40.37% | 19.01% | 3.85% | -2.26% | -0.48% |
| Total Other Income/Expenses | -5.17M | -2.54M | -1.43M | -985.00K | -1.96M | -152.00K | -167.47K | -77.09K |
| Income Before Tax | -16.80M | -10.40M | -1.77M | -3.98M | -1.40M | 136.00K | -172.11K | -25.28K |
| Income Before Tax Ratio | -59.00% | -41.90% | -11.05% | -50.48% | -16.73% | 1.62% | -2.24% | -0.48% |
| Income Tax Expense | -11.00K | -484.00K | 581.00K | -297.00K | 261.00K | 62.00K | 210.00K | 143.00K |
| Net Income | -16.78M | -9.92M | -2.35M | -3.68M | -1.66M | 74.00K | -172.11K | -25.28K |
| Net Income Ratio | -58.96% | -39.95% | -14.67% | -46.71% | -19.85% | 0.88% | -2.24% | -0.48% |
| EPS | -0.17 | -0.11 | -0.03 | -0.06 | -0.03 | 0.00 | -0.17 | -0.03 |
| EPS Diluted | -0.17 | -0.11 | -0.03 | -0.06 | -0.03 | 0.00 | -0.17 | -0.03 |
| Weighted Avg Shares Out | 99.18M | 92.48M | 70.40M | 65.32M | 55.63M | 60.92M | 1.03M | 1.00M |
| Weighted Avg Shares Out (Dil) | 99.18M | 92.48M | 70.40M | 65.32M | 55.63M | 60.92M | 1.03M | 1.00M |
Nanalysis Scientific Corp. (NSCIF) Q3 2024 Earnings Call Transcript
Nanalysis Scientific Corp. (OTCQX:NSCIF) Q3 2024 Earnings Conference Call November 21, 2024 5:00 PM ET Company Participants Matthew Selinger - Investor Relations Sean Krakiwsky - Founder and CEO Randall McRae - Chief Financial Officer Conference Call Participants Operator Good afternoon,...
Nanalysis Announces Third Quarter 2024 Results
Company Achieved 50% YoY Revenue Growth & Positive EBITDA CALGARY, AB , Nov. 21, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research...
Nanalysis Announces Third Quarter 2024 Conference Call
Hosting Call at 5:00 pm ET on Thursday, November 21st European Q&A Session on Friday, November 22nd at 8:30am ET CALGARY, AB , Nov. 7, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable...
Nanalysis to Present at the LD Micro Main Event XVII
Presentation at 3:00 PM PT/6:00 PM ET on Wednesday, October 30th CALGARY, AB , Oct. 15, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and...
Nanalysis to Present at the LD Micro Main Event XVII
Presentation at 3:00 PM PT/6:00 PM ET on Wednesday, October 30th CALGARY, AB , Oct. 15, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and...
Nanalysis Scientific Corp. to Present at the 2024 Cantech Letter Conference in Toronto, ON
Calgary, Alberta--(Newsfile Corp. - October 3, 2024) - Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF), a leader in portable NMR machines and MRI technology for industrial and research applications, is pleased to announce its participation at the upcoming Cantech Letter...
Nanalysis Announces Second Quarter 2024 Results
Record Revenue and Positive EBITDA CALGARY, AB , Aug. 28, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications announces second quarter results...
Nanalysis Announces Second Quarter 2024 Conference Call
Hosting Call at 5:00 pm ET on Wednesday, August 28th European Q&A Session on Thursday August 29th at 8:30am ET CALGARY, AB , Aug. 14, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in...
Nanalysis Announces New Director and Results of AGM
CALGARY, AB , June 28, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("Nanalysis" or the "Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), is pleased to report that all proposed resolutions were approved at the Company's Annual General and Special Meeting of...
Nanalysis Scientific Corp. (NSCIF) Q1 2024 Earnings Call Transcript
Nanalysis Scientific Corp. (OTCQX:NSCIF) Q1 2024 Results Conference Call May 29, 2024 5:00 PM ET Company Participants Matthew Selinger - Investor Relations Sean Krakiwsky - Founder and CEO Randall McRae - Chief Financial Officer Conference Call Participants Stefan Quenneville -...
Source: https://incomestatements.info
Category: Stock Reports